Novo Nordisk stock forecast
Want to see NVO full AI Analyst Report?
Novo Nordisk (NVO) Stock Forecast & Price Target
NVO Analyst Ratings
NVO Stock 12 Month Forecast
Average Price Target
$43.04▲(13.80% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Evan Seigerman | BMO Capital | $40→$44 | hold | 16.34%Upside | Reiterated | 11/05/26 | ||
| Kerry Holford | Berenberg Bank | $47 | hold | 24.27%Upside | Reiterated | 10/13/26 | ||
| Jefferies | $42.20 | hold | 11.58%Upside | Reiterated | 09/22/26 | |||
| Michael Nedelcovych | TD Cowen | $42 | hold | 11.05%Upside | Reiterated | 09/22/26 | ||
| Thibault Boutherin | Morgan Stanley | $40 | sell | 5.76%Upside | Downgraded | 09/11/26 | ||
| Jasper Hellweg | Argus Research | ― | hold | ― | Reiterated | 08/07/26 | ||
| James Quigley | Goldman Sachs | $48→$44 | hold | 16.34%Upside | Reiterated | 08/06/26 | ||
| Martin Brenoe | Nordea Markets | ― | hold | ― | Downgraded | 02/24/26 | ||
| Emmanuel Papadakis | Deutsche Bank | ― | hold | ― | Downgraded | 02/23/26 | ||
| Rajesh Kumar | HSBC | $47→$54 | hold | 42.78%Upside | Reiterated | 12/10/25 | ||
| Richard Vosser | J.P. Morgan | ― | buy | ― | Reiterated | 11/24/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Evan SeigermanBMO Capital | HoldReiterated$40→$44 | 11/05/26 | 16.34%Upside | ||
| Kerry HolfordBerenberg Bank | HoldReiterated$47 | 10/13/26 | 24.27%Upside | ||
| HoldReiterated$42.20 | 09/22/26 | 11.58%Upside | |||
| Michael NedelcovychTD Cowen | HoldReiterated$42 | 09/22/26 | 11.05%Upside | ||
| Thibault BoutherinMorgan Stanley | SellDowngraded$40 | 09/11/26 | 5.76%Upside | ||
| Jasper HellwegArgus Research | HoldReiterated | 08/07/26 | ― | ||
| James QuigleyGoldman Sachs | HoldReiterated$48→$44 | 08/06/26 | 16.34%Upside | ||
| Martin BrenoeNordea Markets | HoldDowngraded | 02/24/26 | ― | ||
| Emmanuel PapadakisDeutsche Bank | HoldDowngraded | 02/23/26 | ― | ||
| Rajesh KumarHSBC | HoldReiterated$47→$54 | 12/10/25 | 42.78%Upside | ||
| Richard VosserJ.P. Morgan | BuyReiterated | 11/24/25 | ― |
Best Analysts Covering Novo Nordisk
Copying Richard Vosser's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +0.86% per trade.
Copying Richard Vosser's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +4.43% per trade.
Copying Richard Vosser's trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +23.16% per trade.
NVO Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 13 | 15 | 16 | 10 |
| Sell | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 8 | 13 | 16 | 17 | 11 |
In the current month, NVO has received 0 Buy Ratings, 10 Hold Ratings, and 1 Sell Ratings. NVO average Analyst price target in the past 3 months is 43.04.
NVO Financial Forecast
NVO Earnings Forecast
Next quarter’s earnings estimate for NVO is $0.66 with a range of $0.49 to $0.73. The previous quarter’s EPS was $0.87. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
NVO Sales Forecast
Next quarter’s sales forecast for NVO is $11.83B with a range of $11.11B to $12.50B. The previous quarter’s sales results were $12.19B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

